$BLCM

Bellicum Pharmaceuticals Inc

  • NASDAQ
  • Health Technology
  • Biotechnology
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing

PRICE

$1.46 -

Extented Hours

VOLUME

17,908

DAY RANGE

1.42 - 1.55

52 WEEK

1.34 - 4.04

Join Discuss about BLCM with like-minded investors

profile
@dros #droscrew
recently

+Initiations 2/16: $BLCM $FLNC $GDEN $ITCI $VCSA . -Initiations 2/16: $NU

141 Replies 15 👍 7 🔥

VH
@vhmoura #StockTraders.NET
recently

what is going on with $BLCM

81 Replies 11 👍 7 🔥

profile
@dros #droscrew
recently

Downgrades 10/30: $APPS $BLCM $BPMC $CLBK $CXO $FITB $IPHI $NFE $NOK $NTCT $NUVA $PE $PRO $TEAM $YNDX

98 Replies 6 👍 7 🔥

Key Metrics

Market Cap

13.34 M

Beta

0.85

Avg. Volume

23.71 K

Shares Outstanding

8.61 M

Yield

0%

Public Float

0

Next Earnings Date

2022-08-11

Next Dividend Date

Company Information

Bellicum is a clinical stage biopharmaceutical company striving to deliver cures through controllable cell therapies. The company's next-generation product candidates are differentiated by powerful cell signaling technologies designed to produce more effective CAR-T cell therapies. Bellicum's GoCAR-T® product candidates, BPX-601 and BPX-603, are designed to be more efficacious CAR-T cell products capable of overriding key immune inhibitory mechanisms.

CEO: Richard Fair

Website:

HQ: 2710 Reed Road Houston, 77051 Texas

Related News